| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,300 | $30 | $372.9K |
| J3262 | Injection, tocilizumab, 1 mg | 45,120 | $10 | $225.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,370 | $30 | $191.6K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 27,800 | $1 | $111.2K |
| J0897 | Injection, denosumab, 1 mg | 5,820 | $20 | $104.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,050 | $10 | $99.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 620 | $60 | $38.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $90 | $24.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $90 | $21.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 230 | $50 | $10.4K |